Calprotectin and Inflammatory Bowel Disease - Insights

September 6, 2016 The differential diagnosis for inflammatory bowel disease (IBD) includes irritable bowel syndrome (IBS). While the clinical presentation is similar, IBD is an inflammatory disease, while IBS is a noninflammatory disease. The usual approach is to develop a comprehensive clinical picture and family history, but without endoscopy or biopsy, it's virtually impossible to distinguish whether the patient is suffering from IBD or IBS. The stool calprotectin test (Calprotectin, Feces; Test ID: CALPR) offers a noninvasive option to assess for localized inflammation, potentially eliminating the need for biopsy in patients with IBS.PresenterMelissa Snyder, Ph.D., is an Assistant Professor of Laboratory Medicine and Pathology and aConsultant in the Division of Clinical Biochemistry Laboratory at Mayo Clinic in Rochester, Minnesota.TranscriptOur speaker for this program is Dr. Melissa Snyder, a Professor of Laboratory Medicine and Pathology at Mayo Clinic, as well as a consultant i...